Ming Yin
6PUBLICATIONS
21CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 17, 2025
The ATR Inhibitor Elimusertib in Combination with Cisplatin in Patients with Advanced Solid Tumors: A California Cancer Consortium Phase I Trial (NCI 10404).Mamta Parikh, Nataliya V Uboha, Naoko Takebe
|Mar 19, 2022
Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma.Yuanquan Yang, Sarah P Psutka, Anish B Parikh
|Feb 09, 2022
Salvage nivolumab and ipilimumab after prior anti-PD-1/PD-L1 therapy in metastatic renal cell carcinoma: A meta-analysis.Yuanquan Yang, Sherry V Mori, Mingjia Li
|Nov 20, 2020
Increased bleeding risk associated with concurrent vascular endothelial growth factor receptor tyrosine kinase inhibitors and low-molecular-weight heparin.Sandip H Patel, Tiffany L George, Tzu-Fei Wang
|Oct 24, 2020
Alterations of DNA damage response genes correlate with response and overall survival in anti-PD-1/PD-L1-treated advanced urothelial cancer.Monika Joshi, Petros Grivas, Amir Mortazavi
|Nov 08, 2019
Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high-risk localized prostate cancer.Ming Yin, Jing Zhao, Paul Monk
Pageof 1
Frequent Collaborators
1 joint publications
Tiffany L George
1 joint publications
Tzu-Fei Wang
1 joint publications
Anish B Parikh
1 joint publications
Sarah P Psutka
1 joint publications
Mamta Parikh
1 joint publications
Nataliya V Uboha
1 joint publications
Naoko Takebe
1 joint publications
Kit Tam
1 joint publications
Philippe L Bedard
1 joint publications
Kari B Wisinski
